Tools and criteria to select patients with advanced Parkinson's disease for device-aided therapies: a narrative review.

"Conflict of interest HRM received a PhD research grant from the University Medical Center Groningen, Junior Scientific Masterclass [grant number GR-AGIKO 18–02]. This PhD project includes the development and validation of the Dutch DAT Screening tool (D-DATS). He declares no financial interests related to this work. TH has no conflict of interests relevant to this work. She reports having received honorary for talks for AbbVie, Britannia, Nordic Infucare, Ipsen, Convatec, and NeuroDerm. In addition, she is PI at a study funded by AbbVie, and a DMC board member at a study funded by Lundbeck. JS has no disclosures to report regarding this contribution. He has given lectures and served on advisory boards for AbbVie and Ever Pharma. OP has no competing interests to declare relevant to the content of this article. EB has no disclosures to report regarding this contribution. He received funding from Dutch Heart Foundation matched by an unrestricted grant from Stryker through national industry platform in the domain of acute stroke. He participated as chair and committee member on several prevention programs from National Health Care research program ZonMw. TvL has no nothing to disclose which is directly or indirectly related to the work submitted for publication. He has received consulting fees from AbbVie, Britannia Pharm., Eurocept, and Clexio, and research grants from the Michael J. Fox Foundation, the Dutch Brain Foundation, and the University Medical Center Groningen."

"Funding This work was supported by the University Medical Center Groningen, Junior Scientific Masterclass [grant number GR-AGIKO 18-02]. The funding source did not have a role in the preparation of this manuscript."